Internal Medicine, Hematology & Oncology · Chapel Hill, NC
NPI
1780747378
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
101 Manning Dr
Chapel Hill, NC, 27599
Phone (919) 966-4996
Groups this clinician bills Medicare through
Medicare paid, 2024
$34K
371 services
Medicare patients, 2024
148
Average age 74
Drug cost, 2024
$8.1M
948 prescriptions
Company payments, 2024
$41.77
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hendrik W Vandeventer was code 99215 (office e&m - established), 148 times for 83 patients. In total Hendrik W Vandeventer billed 371 services in 16 codes, and Medicare paid $34K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 148 | 83 | $90.14 | $13K |
| 99233 Hospital E&M - Subsequent | Facility | 103 | 24 | $87.94 | $9,058 |
| 99215 Office E&M - Established | Office | 23 | 21 | $113.47 | $2,610 |
| 99205 Office E&M - New | Facility | 18 | 18 | $134.76 | $2,426 |
| 99223 Hospital E&M - Initial | Facility | 18 | 17 | $128.85 | $2,319 |
| 99214 Office E&M - Established | Facility | 16 | 15 | $66.32 | $1,061 |
| 99214 Office E&M - Established | Office | 14 | 12 | $82.23 | $1,151 |
By year: 2022 $41K for 444 services; 2023 $50K for 530 services; 2024 $34K for 371 services.
Medicare prescription drug claims, 2024
In 2024, the drug Hendrik W Vandeventer prescribed most often to Medicare patients was Jakafi (Ruxolitinib Phosphate), with 77 prescriptions and refills. In total Hendrik W Vandeventer wrote 948 Medicare prescriptions that cost $8.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Jakafi Ruxolitinib Phosphate | 77 | 77 | 13 | $1.3M |
| Ojjaara Momelotinib Dihydrochloride | 59 | 59 | Under 11 | $1.6M |
| Imbruvica Ibrutinib | 52 | 56 | Under 11 | $776K |
| Hydroxyurea Generic | 38 | 72 | Under 11 | $1,018 |
| Brukinsa Zanubrutinib | 38 | 38 | Under 11 | $540K |
| Tacrolimus Generic | 37 | 39 | Under 11 | $2,974 |
| Valacyclovir Valacyclovir Hcl | 35 | 65 | 11 | $1,026 |
| Calquence Acalabrutinib Maleate | 32 | 32 | Under 11 | $487K |
| Eliquis Apixaban | 28 | 34 | Under 11 | $19K |
| Inqovi Decitabine/Cedazuridine | 23 | 23 | Under 11 | $184K |
| Promacta Eltrombopag Olamine | 22 | 22 | Under 11 | $763K |
| Cyclosporine Modified Cyclosporine, Modified | 22 | 22 | Under 11 | $3,173 |
| Amlodipine Besylate Generic | 20 | 22 | Under 11 | $18.83 |
| Fluconazole Generic | 15 | 15 | Under 11 | $299 |
| Escitalopram Oxalate Generic | 15 | 23 | Under 11 | $75.08 |
Brand drugs: 460 claims; generic drugs: 488 claims; opioid claims: 23.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Hendrik W Vandeventer $41.77 ($41.77 in general payments such as food, travel and fees) from 1 company. The largest payer was Incyte Corporation with $41.77.
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation INCY | 1 | $41.77 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.